Clinical Trials
3 trialsNCT06538038 2026-03-27
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
PrECOG, LLC.
Recruiting
NCT03790397 2022-06-03
OSIREX
Fundación GECP
Completed
NCT03532698 2020-07-23
Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Unknown